Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62.7M
-
Number of holders
-
206
-
Total 13F shares, excl. options
-
54.9M
-
Shares change
-
-755K
-
Total reported value, excl. options
-
$1.58B
-
Value change
-
-$221M
-
Put/Call ratio
-
0.89
-
Number of buys
-
120
-
Number of sells
-
-138
-
Price
-
$28.72
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q1 2020
320 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q1 2020.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 206 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.9M shares
of 62.7M outstanding shares and own 87.62% of the company stock.
Largest 10 shareholders include FMR LLC (7.79M shares), VANGUARD GROUP INC (4.83M shares), Capital International Investors (3.68M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.96M shares), BlackRock Inc. (2.75M shares), GREAT POINT PARTNERS LLC (1.82M shares), Invesco Ltd. (1.76M shares), STATE STREET CORP (1.69M shares), BOXER CAPITAL, LLC (1.53M shares), and Bellevue Group AG (1.42M shares).
This table shows the top 206 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.